In vitro degradation of β-amyloid[25-35] peptide

被引:1
|
作者
Jost, K [1 ]
Varga, J [1 ]
Penke, S [1 ]
Zarándi, M [1 ]
机构
[1] Univ Szeged, Fac Med, Dept Med Chem, H-6720 Szeged, Hungary
来源
PROTEIN AND PEPTIDE LETTERS | 2001年 / 8卷 / 06期
关键词
D O I
10.2174/0929866013409076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some amyloid-derived peptides show their toxic effects only after a long "aging" period performed several days at pH 7.4 and 37 degreesC far cluster formation. Our experiments show that long aging of beta -amyloid[25-35] under physiological conditions results in peptide band cleavage between Asn(27) and Lys(28). Relatively short incubation time (24 hours) and absence of Ca2+ ions prevent peptide cleavage and results in good aggregation of beta -amyloids.
引用
收藏
页码:423 / 428
页数:6
相关论文
共 50 条
  • [1] Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25-35 fibrillation
    Hashimoto, Michio
    Shahdat, Hossain Md
    Katakura, Masanori
    Tanabe, Yoko
    Gamoh, Shuji
    Miwa, Koji
    Shimada, Toshio
    Shido, Osamu
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (04): : 289 - 296
  • [2] Chemical degradation of beta-amyloid [25-35] peptide under physiological conditions
    Jost, K
    Varga, J
    Szabo, Z
    Penke, B
    Zarandi, M
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 141 - 141
  • [3] Intracellular mechanisms of amyloid β-peptide Aβ25-35 induced neurite outgrowth inhibition in vitro
    Larner, AJ
    [J]. ALZHEIMERS REPORTS, 1998, 1 (01): : 55 - 59
  • [4] Interactions between gold nanoparticles and amyloid β25-35 peptide
    Peng, Jian
    Weng, Jian
    Ren, Lei
    Sun, Li-Ping
    [J]. IET NANOBIOTECHNOLOGY, 2014, 8 (04) : 295 - 303
  • [5] The methylated compounds affect the aggregation of amyloid peptide (25-35)
    Grimaldi, M.
    Di Marino, S.
    Scrima, M.
    Iuliano, A.
    Polverino, A.
    Sorrentino, G.
    D'Ursi, A. M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S31 - S31
  • [6] Conformations and Biological Activities of Amyloid Beta Peptide 25-35
    Millucci, L.
    Ghezzi, L.
    Bernardini, G.
    Santucci, A.
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2010, 11 (01) : 54 - 67
  • [7] Solution structure of amyloid β-peptide (25-35) in different media
    D'Ursi, AM
    Armenante, MR
    Guerrini, R
    Salvadori, S
    Sorrentino, G
    Picone, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) : 4231 - 4238
  • [8] Structural analysis of amyloid β peptide fragment (25-35) in different microenvironments
    Shanmugam, G
    Jayakumar, R
    [J]. BIOPOLYMERS, 2004, 76 (05) : 421 - 434
  • [9] βA amyloid peptide (25-35) induced APP expression in cultured astrocytes
    Moreno-Flores, MT
    Salinero, O
    Wandosell, F
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1998, 52 (06) : 661 - 671
  • [10] Channel formation by a neurotoxic beta amyloid peptide, A beta 25-35
    Lin, MC
    Mirzabekov, T
    Kagan, B
    [J]. NEURODEGENERATIVE DISEASES: MOLECULAR AND CELLULAR MECHANISMS AND THERAPEUTIC ADVANCES, 1996, : 331 - 336